NCT05259488 Preoperative Immunonutrition in Laparoscopic Total D2 Gastrectomy Status COMPLETED Phase N/A
NCT05253053 To Evaluate Efficacy and Safety of TT-00420 (Tinengotinib) as Monotherapy and Combination Therapy in Patients With Advanced Solid Tumors Status COMPLETED Phase PHASE1/PHASE2
NCT05241899 A Phase II Clinical Study of Fruquintinib Combined With RC48 in the Treatment of Previously Treated HER2-positive Locally Advanced or Metastatic Gastric or Gastroesophageal Junction (G/GEJ) Cancer Status UNKNOWN Phase PHASE2
NCT05239143 P-MUC1C-ALLO1 Allogeneic CAR-T Cells in the Treatment of Subjects With Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05238883 A Study of HFB200301 as a Single Agent and in Combination With Tislelizumab in Adult Patients With Advanced Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05238584 Total Versus Partial Omentectomy in the Treatment of Gastric Cancer Status UNKNOWN Phase NA
NCT05235932 the Clinical Efficacy of Robotic and Laparoscopic Radical Total Gastrectomy in Locally Advanced Middle and Upper Gastric Cancer Status NOT_YET_RECRUITING Phase NA
NCT05233436 PF-07265028 As Single Agent And In Combination With Sasanlimab in Advanced or Metastatic Solid Tumors Status TERMINATED Phase PHASE1
NCT05229874 Effect of CNSI vs. ICG in Lymph Node Tracing During Gastrectomy Status ACTIVE_NOT_RECRUITING Phase PHASE2
NCT05228743 Conversion Therapy of Hyperthermic Intraperitoneal Chemotherapy Plus Chemotherapy and Chemotherapy in Stage IV Gastric Cancer Status UNKNOWN Phase NA
NCT05227378 Safety and Efficacy of Personalized Neoantigen Vaccine in Advanced Gastric Cancer Status UNKNOWN Phase NA
NCT05219539 Questionnaire Survey of the Advanced Training Program for Laparoscopic Radical Gastrectomy Status COMPLETED Phase N/A
NCT05216237 A Study to Evaluate the Efficacy and Safety of Sintilimab Plus Apatinib and Chemotherapy in Patients With HER-2 Negative Microsatellite Stability (MSS) Advanced or Metastatic Gastric (GC) or Gastroesophageal Junction (GEJ) Cancer Status UNKNOWN Phase PHASE2
NCT05215574 Study of NGM831 as Monotherapy and in Combination With Pembrolizumab or Pembrolizumab and NGM438 in Advanced or Metastatic Solid Tumors Status ACTIVE_NOT_RECRUITING Phase PHASE1
NCT05205330 Vorbipiprant (CR6086) / Balstilimab (AGEN2034) Combination in Stage IV Refractory pMMR - MSS CRC, and Other Metastatic GI Cancers Status ACTIVE_NOT_RECRUITING Phase PHASE1/PHASE2
NCT05203549 Consistency Between Treatment Responses in PDO Models and Clinical Outcomes in Gastric Cancer Status UNKNOWN Phase N/A